Über diesen Podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
79 Folgen · Investeren
Hims House
Über diesen Podcast
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to GLP-1s, compounding, and the future of healthcare. New episodes every week. <br/><br/><a href="https://himshouse.substack.com?utm_medium=podcast">himshouse.substack.com</a>
Neue Folgen
- Brazil's 2nd-largest telehealth CEO on how Hims & Hers should enter Brazil 🇧🇷8. Okt. · 52 Min.
- Finnrick CEO on gray market peptides, fake bodega vials, and China's manufacturing prowess1. Okt. · 40 Min.
- OpenLoop CEO: the peptide gray market is 2-3x bigger than analyst estimates, likely $6-8 billion16. Sept. · 30 Min.
- HIMS stock token hit $132 on Robinhood over the weekend due to ... $BONER coin?! 😳3. Sept. · 39 Min.
- 🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub2. Sept. · 54 Min.
- Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro26. Aug. · 1 Std. 00 Min.
- Enhanced Group CEO: Hot peptide summer is coming — but likely not till 20277. Aug. · 54 Min.
- 🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem27. Juli · 1 Std. 00 Min.
- The FDA peptides vote is days away. This insider expects approval15. Juli · 1 Std. 01 Min.
- Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share7. Juli · 1 Std. 01 Min.
sharemy.show/de/hims-house
Für ein Plakat oder eine Folie.